Diagnostic and Treatment Patterns in Management of Male Patients with Nongonococcal Urethritis: Results of Russian Multicentral Cross-Sectional Study

The aim of the study was to estimate the diagnostic and treatment patterns in the management of acute nongonococcal urethritis (NGU) in males in some cities of Russia. Retrospective cross-sectional study was conducted in 2009 in 5 centers of 4 cities in the _ Central Part of Russia (Kaluga, Pskov, Smolensk - 2 cen- tres and Tula). The data on the diagnostic and treatment approaches to the management of NGU in male subjects >16 years old were collected and analyzed with the use of special ly designed case report forms. 556 cases of acute urethritis were analyzed during the study. The diagnosis of NGU was confirmed in 401 cases. The average age of the patients was 29.8 years (16-68 years). The following diagnostic methods were used in 95% of the cases: urethral smear microscopy (314/82.4%), C.trachomatis - PCR (113/29.7%), ELISA (155/40.7%); T.vaginalis - PCR (106/27.8%); U.urealyticum and M.hominis, respectively - bacteriology (140/36.7% and 126/33.1%), PCR (110/28.9% and 108/28.3%); M.genitalium - PCR (110/28.9%). The treatment patterns included antimicrobials AMs alone in 60.3, and AMs + non-AMs in 37.8% of the cases. The most frequently prescribed AMs were azithromycin (27.5%), fluconazole (16.4%), doxycycline (13.6%), metronidazole (11.2%), of loxacine (7.3%), ceftriaxone (4.4%), josamycin (4.2). According to the results use of the standard methods for NGU diagnosis was rather rare. The use of PCR for atypical pathogens was the following: C.trachomatis 29.7%, U.urealyticum 36.7%, M.hominis 28.9%, M.genitalium 28.3%. Doubtful culture methods were used for detection of U.urealyticum and M.hominis (36.7% and 33.1%). The AMs treatment in some cases was not in compliance with the up-to-date practical guidelines for STD and NGU.

acute urethritis, males, nongonococcal urethritis, nongonococcal urethritis, diagnostic patterns, treatment, antimicrobials

1. Terris M. K. Sajadi K. P. Common Problems of the Urethra. Urethritis. Updated: Aug 10, 2009. Available from: http://emedicine. medscape. com/article/438091-overview.

2. Clinical Manual of Urology / Hanno P. M., Malkowicz S. B., Wein A. J. (eds.), 3rd Edition. McGraw-Hill, N. Y. 2001.

3. Kucuna В. И., Сидурский С. В., Фаттяхетдинов Р. Ш. и др. Сравнительная эффективность лечения негонококкового уретрита у мужчин с помощью генерического и оригинального азитромицина. Клиническая дерматология и венерология 2008; 5: 64-66.

4. Какорина Е. П., Авдеева Л. H., Иванова М. А. и др. ЦНИИ ОИЗ. Заболеваемость хламидийной инфекцией в субъектах РФ (2006-2007 гг.). Available from: http://www.mednet.ru/images/stories/files/statistika/dermatovenerologicheskaya_sluzhba/2008/zabolevaemost_hlamidiinoi_infek ciei_v_subektah_rf_2007.pdf

5. Гомберг М. А., Соловьев А. М., Ковалык В. П. Негонококковые уретриты у мужчин: этиология и обоснование этиотропной терапии. Лечащий врач 2006; 7: 26-31.

6. Workowski K. A., Berman S. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR Recomm Rep. 2010; 59 (RR-12): 1-10.

7. Shahmanesh M., Moi H., Lassau F., Janier M. IUSTI/WHO. 2009 European guideline on the management of male non-gonococcal urethritis. Int J STD AIDS 2009; 20: 7: 458-464.

8. Urogenital infections. European Association of Urology / Naber K. G., Schaeffer A. J., Heyns C. et al., eds. 2010.

9. Протокол ведения больных «Инфекции, передаваемые половым путем». «Урогенитальная хламидийная инфекция». Под ред. В. И. Кисиной. М.: Ньюдиамед. 2011: 164-191.

10. Российское общество дерматовенерологов. Инфекции, передаваемые половым путем. Клинические рекомендации. Дерматовенерология / Под ред. А. А. Кубановой. М.: ДЭКС-Пресс. 2010; 428.

11. Lanjouw E., Ossewaarde J. M., Stary A. et al. 2010 European guideline for the management of Chlamydia trachomatis infections. Int J STD AIDS 2010; 21: 11: 729-737.

12. Watson E. J., Templeton A., Russell I. et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002; 51: 1021-1031.

13. Протокол ведения больных «Инфекции, передаваемые половым путем». «Урогенитальный трихомониаз» / Под ред. В. И. Кисиной. М.: Ньюдиамед. 2011; 206-244.

14. Кубанова А. А., Рахматуллина М. Р. Урогенитальные инфекционные заболевания, вызванные генитальными микоплазмами. Клинические рекомендации. Consilium Medicum 2009; 6: 32-36.

15. Инструкция к препарату Зетамакс ретард. http://www.vidal.ru/ poisk_preparatov/zetamax-retard.htm.

16. Cornely O. A., Böhme A., Buchheidt D. et al. Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82: Suppl 2: S186-200.

17. Ship J. A., Vissink A., Challacombe S. J. Use of prophylactic antifungals in the immunocompromised host. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: S6. e1-14.

18. Cruciani M., Mengoli C., Malena M. et al. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl 2006; 12: 5: 850-885.

19. Patterson R., Grammer L. C., Greenberger P. A. Allergic Diseases: Diagnosis and Management. Lippincott Williams & Wilkins; 5th edition, 1997; 634.

20. Babe K. S., Serafin W. E. Histamine bradykinin, and their antagonists. In: Hardman J. G., Limbird L. E., Molinoff P. В., Ruddon R. W., eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996: 581-600.

21. Fung M., Scott K. C., Kent C. K. et al. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007; 83: 304-309.

22. Kissinger P. J., Reilly K., Taylor S. N. et al. Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men. Sex Transm Dis 2009; 36: 498-500.

23. Workowski K. A., Berman S. M., Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006; 55 (RR-11): 1-94.